Construction of competing-risk nomograms and identification of optimal candidates for aggressive therapy in gastric cancer with peritoneal metastasis: a population-based study

Read full text Summarise with VIRAT
Authors: Zhifan Zhang, Chenchen Lu, Wen Wang, Jing Yang, Zaixiang Tan
Cited by: 0
References: 39

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: The optimal treatment strategies for gastric cancer with peritoneal metastasis (GCPM) are extensively debated, especially regarding the appropriateness of aggressive local treatments. This study aimed to construct robust competing-risk nomograms for prognostic prediction and to establish a novel risk-stratification system to facilitate individualized therapeutic decision-making. Methods: Patients diagnosed with GCPM between 2010 and 2015 were identified from the Surveillance, Epidemiology, and End Results (SEER) database and randomly divided into training and validation cohorts at a 7:3 ratio. Propensity score matching (PSM) was applied to evaluate the survival impact of different treatment strategies. Independent prognostic factors in the training cohort were selected using a combination of least absolute shrinkage and selection operator (LASSO) regression and stepwise Akaike information criterion (AIC), and these variables were subsequently used to construct Cox [for overall survival (OS)] and Fine-Gray [for cancer-specific survival (CSS)] nomograms. Model discrimination, calibration, predictive accuracy, and clinical utility were assessed using the concordance index (C-index), receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Risk stratification was further performed based on the nomogram-derived scores, and treatment benefits were analyzed across different risk groups. Results: A total of 4,280 patients were included, comprising 2,996 in the training cohort and 1,284 in the validation cohort. PSM analysis demonstrated that, among unstratified patients, aggressive therapy significantly improved survival compared with chemotherapy-based treatment (P

Fields of Study & Subjects

Intraperitoneal and Appendiceal Malignancies Gastric Cancer Management and Outcomes Pancreatic and Hepatic Oncology Research

Publication details

Journal / source
Translational Cancer Research
Volume
15
Issue
3
Pages
161–161
Publication date
1 March 2026
Language
EN